Adelaide Research & Scholarship: Search

Search

Results 1-9 of 9 (Search time: 0.003 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2004	Apolipoprotein-D: A novel cellular marker for HGPIN and prostate cancer	Hall, R.; Horsfall, D.; Stahl, J.; Vivekanandan, S.; Ricciardelli, C.; Stapleton, A.; Scardino, P.; Neufing, P.; Tilley, W.
	2003	Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues	Neufing, P.; Kalionis, B.; Horsfall, D.; Ricciardelli, C.; Stahl, J.; Vivekanandan, S.; Raymond, W.; Tilley, W.
	1999	Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer	Ricciardelli, C.; Quinn, D.; Raymond, W.; McCaul, K.; Sutherland, P.; Stricker, P.; Grygiel, J.; Sutherland, R.; Marshall, V.; Tilley, W.; Horsfall, D.
	2002	A potential autocrine role for vascular endothelial growth factor in prostate cancer	Jackson, M.; Roberts, J.; Heckford, S.; Ricciardelli, C.; Stahl, J.; Horsfall, D.; Tilley, W.
	2001	Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1	Sakko, A.; Ricciardelli, C.; Mayne, K.; Tilley, W.; LeBaron, R.; Horsfall, D.
	2003	Modulation of prostate cancer cell attachment to matrix by Versican	Sakko, A.; Ricciardelli, C.; Mayne, K.; Suwiwat, S.; LeBaron, R.; Marshall, V.; Tilley, W.; Horsfall, D.
	2008	Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential	Ricciardelli, C.; Jackson, M.; Choong, C.; Stahl, J.; Marshall, V.; Horsfall, D.; Tilley, W.
	2004	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer	Suwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V.; LeBaron, R.; Raymond, W.; Tilley, W.; Horsfall, D.
	2010	Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome	Callen, D.; Ricciardelli, C.; Butler, M.; Stapleton, A.; Stahl, J.; Kench, J.; Horsfall, D.; Tilley, W.; Schulz, R.; Nesland, J.; Neilsen, P.; Kumar, R.; Holm, R.